LENALIDOMIDE GASTRO-RETENTIVE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF

LENALIDOMIDE GASTRO-RETENTIVE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF

The invention discloses a lenalidomide gastro-retentive sustained-release tablet and a preparation method thereof. The sustained-release tablet comprises 3 wt % to 14 wt % of lenalidomide, 14 wt % to 68 wt % of release enhancer with low bulk density, 23 wt % to 70 wt % of sustained-release material...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU, Feng, TAN, Xiaofeng, LAI, Shuting, LUO, Huafeng, HE, Jingyu
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIU, Feng
TAN, Xiaofeng
LAI, Shuting
LUO, Huafeng
HE, Jingyu
description The invention discloses a lenalidomide gastro-retentive sustained-release tablet and a preparation method thereof. The sustained-release tablet comprises 3 wt % to 14 wt % of lenalidomide, 14 wt % to 68 wt % of release enhancer with low bulk density, 23 wt % to 70 wt % of sustained-release material with low bulk density, and the balance of other pharmaceutically acceptable excipients, wherein the bulk density of the release enhancer ranges from 0.24 g/cm3 to 0.52 g/cm3; and the bulk density of the sustained-release material ranges from 0.29 g/cm3 to 0.51 g/cm3. The sustained-release tablet of the invention is in a floating state in a gastric environment, is not directly discharged from a stomach due to gastric emptying, has an effect of gastric retention, and is not easily discharged with substances contained in the stomach, and has a high drug bioavailability and small side effects.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2021128476A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2021128476A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2021128476A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAURuEsDqK-wwXngqmirlfz1wbSpCS3rqVInEQL9f3RwQdwOvBx5qpz8OysCY01oAsniaGIEHixV1DqkrD1MF9z4AQSPjkIsTfURrQcWWzw1EDqYEhqRIRqqWb34THl1a8Lta4g57rI46vP0zjc8jO_-y6Vm1Lr8rg77Flv_7s-UdgxrA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LENALIDOMIDE GASTRO-RETENTIVE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF</title><source>esp@cenet</source><creator>LIU, Feng ; TAN, Xiaofeng ; LAI, Shuting ; LUO, Huafeng ; HE, Jingyu</creator><creatorcontrib>LIU, Feng ; TAN, Xiaofeng ; LAI, Shuting ; LUO, Huafeng ; HE, Jingyu</creatorcontrib><description>The invention discloses a lenalidomide gastro-retentive sustained-release tablet and a preparation method thereof. The sustained-release tablet comprises 3 wt % to 14 wt % of lenalidomide, 14 wt % to 68 wt % of release enhancer with low bulk density, 23 wt % to 70 wt % of sustained-release material with low bulk density, and the balance of other pharmaceutically acceptable excipients, wherein the bulk density of the release enhancer ranges from 0.24 g/cm3 to 0.52 g/cm3; and the bulk density of the sustained-release material ranges from 0.29 g/cm3 to 0.51 g/cm3. The sustained-release tablet of the invention is in a floating state in a gastric environment, is not directly discharged from a stomach due to gastric emptying, has an effect of gastric retention, and is not easily discharged with substances contained in the stomach, and has a high drug bioavailability and small side effects.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210506&amp;DB=EPODOC&amp;CC=US&amp;NR=2021128476A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210506&amp;DB=EPODOC&amp;CC=US&amp;NR=2021128476A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU, Feng</creatorcontrib><creatorcontrib>TAN, Xiaofeng</creatorcontrib><creatorcontrib>LAI, Shuting</creatorcontrib><creatorcontrib>LUO, Huafeng</creatorcontrib><creatorcontrib>HE, Jingyu</creatorcontrib><title>LENALIDOMIDE GASTRO-RETENTIVE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF</title><description>The invention discloses a lenalidomide gastro-retentive sustained-release tablet and a preparation method thereof. The sustained-release tablet comprises 3 wt % to 14 wt % of lenalidomide, 14 wt % to 68 wt % of release enhancer with low bulk density, 23 wt % to 70 wt % of sustained-release material with low bulk density, and the balance of other pharmaceutically acceptable excipients, wherein the bulk density of the release enhancer ranges from 0.24 g/cm3 to 0.52 g/cm3; and the bulk density of the sustained-release material ranges from 0.29 g/cm3 to 0.51 g/cm3. The sustained-release tablet of the invention is in a floating state in a gastric environment, is not directly discharged from a stomach due to gastric emptying, has an effect of gastric retention, and is not easily discharged with substances contained in the stomach, and has a high drug bioavailability and small side effects.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAURuEsDqK-wwXngqmirlfz1wbSpCS3rqVInEQL9f3RwQdwOvBx5qpz8OysCY01oAsniaGIEHixV1DqkrD1MF9z4AQSPjkIsTfURrQcWWzw1EDqYEhqRIRqqWb34THl1a8Lta4g57rI46vP0zjc8jO_-y6Vm1Lr8rg77Flv_7s-UdgxrA</recordid><startdate>20210506</startdate><enddate>20210506</enddate><creator>LIU, Feng</creator><creator>TAN, Xiaofeng</creator><creator>LAI, Shuting</creator><creator>LUO, Huafeng</creator><creator>HE, Jingyu</creator><scope>EVB</scope></search><sort><creationdate>20210506</creationdate><title>LENALIDOMIDE GASTRO-RETENTIVE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF</title><author>LIU, Feng ; TAN, Xiaofeng ; LAI, Shuting ; LUO, Huafeng ; HE, Jingyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2021128476A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LIU, Feng</creatorcontrib><creatorcontrib>TAN, Xiaofeng</creatorcontrib><creatorcontrib>LAI, Shuting</creatorcontrib><creatorcontrib>LUO, Huafeng</creatorcontrib><creatorcontrib>HE, Jingyu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU, Feng</au><au>TAN, Xiaofeng</au><au>LAI, Shuting</au><au>LUO, Huafeng</au><au>HE, Jingyu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LENALIDOMIDE GASTRO-RETENTIVE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF</title><date>2021-05-06</date><risdate>2021</risdate><abstract>The invention discloses a lenalidomide gastro-retentive sustained-release tablet and a preparation method thereof. The sustained-release tablet comprises 3 wt % to 14 wt % of lenalidomide, 14 wt % to 68 wt % of release enhancer with low bulk density, 23 wt % to 70 wt % of sustained-release material with low bulk density, and the balance of other pharmaceutically acceptable excipients, wherein the bulk density of the release enhancer ranges from 0.24 g/cm3 to 0.52 g/cm3; and the bulk density of the sustained-release material ranges from 0.29 g/cm3 to 0.51 g/cm3. The sustained-release tablet of the invention is in a floating state in a gastric environment, is not directly discharged from a stomach due to gastric emptying, has an effect of gastric retention, and is not easily discharged with substances contained in the stomach, and has a high drug bioavailability and small side effects.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2021128476A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title LENALIDOMIDE GASTRO-RETENTIVE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A21%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU,%20Feng&rft.date=2021-05-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2021128476A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true